<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>The official Bluesky account of https://psoriasisclub.org&#xA;&#xA;*Please note we do not answer questions here about psoriasis, you will need to join our forum where you will find a friendly bunch of people sharing support and information. &#xA; &#xA;</description><link>https://bsky.app/profile/psoriasisclub.org</link><title>@psoriasisclub.org - PsoriasisClub.Org</title><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mjrdpvxgps25</link><description>This multicentre retrospective study in Germany looked at patients with erythrodermic psoriasis using a wide variety of treatments.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8463.html</description><pubDate>18 Apr 2026 11:32 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mjrdpvxgps25</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mjrb2j3ygk25</link><description>How demographics and family history redefine clearance predictions in psoriasis patients treated with biologics.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8462.html</description><pubDate>18 Apr 2026 10:44 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mjrb2j3ygk25</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mjjv46buts2v</link><description>This study looked at the effectiveness of interleukin-17 inhibitors (IL-17i) in treating anti-TNF-induced Paradoxical psoriasis (PP) in patients with Hidradenitis Suppurativa (HS)&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8461.html</description><pubDate>15 Apr 2026 12:22 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mjjv46buts2v</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mjjujf3jvc2v</link><description>This study constructed a gene carrier with transdermal transfection capabilities, providing a new approach for gene delivery. This system achieves significant therapeutic effects in immune diseases like psoriasis. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8460.html</description><pubDate>15 Apr 2026 12:11 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mjjujf3jvc2v</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mj35mbkqdc2a</link><description>We seem to be stabilising and the forum is back online.&#xA;&#xA;[contains quote post or other embedded content]</description><pubDate>09 Apr 2026 15:44 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mj35mbkqdc2a</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mj2whroj5c2a</link><description>We are aware of some intermittent downtime on our forum and working to fix it. &#xA;&#xA;psoriasisclub.org&#xA;https://psoriasisclub.org</description><pubDate>09 Apr 2026 13:36 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mj2whroj5c2a</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mj2s77ah2s2a</link><description>Glucagon-like peptide-1 receptor (GLP-1RA) agonist therapy is associated with improvement in psoriatic arthritis (PsA) related and metabolic outcomes.&#xA;&#xA;#Psoriasis &#xA;#Psoriaticarthritis&#xA;&#xA;https://psoriasisclub.org/thread-8458.html</description><pubDate>09 Apr 2026 12:20 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mj2s77ah2s2a</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3minzxwrs5c2x</link><description>Around one third of psoriasis patients experience skin pain, this study investigated what is going on. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8457.html</description><pubDate>04 Apr 2026 10:34 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3minzxwrs5c2x</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3midzudqnwk2g</link><description>This study aimed to investigate treatment resistance mechanisms in palmoplantar psoriasis and assess the contribution of IL-17, IL-23, and IL-36α to the differential diagnosis. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8454.html</description><pubDate>31 Mar 2026 11:06 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3midzudqnwk2g</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3midzhxlrrk2g</link><description>This study focused on the level of B-cell types in the whole blood of psoriasis patients and investigated the variability between Bregs and memory B cells and other classified B cells in the blood of psoriasis patients and healthy controls. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8453.html</description><pubDate>31 Mar 2026 10:59 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3midzhxlrrk2g</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mi6vljadzk2g</link><description>Envudeucitinib is a next-generation oral allosteric inhibitor of tyrosine kinase 2 (TYK2) precision‑engineered for maximal 24‑hour TYK2 inhibition to correct immune dysregulation driven by proinflammatory mediators including IL-23 &amp; IL-17&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8452.html</description><pubDate>29 Mar 2026 10:06 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mi6vljadzk2g</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mi226zp2ts2d</link><description>This study aimed to characterise changes in the diversity and composition of oral fungal and bacterial communities in psoriasis patients before and after treatment with IL-17 inhibitors. &#xA;&#xA;#Psoriasis&#xA;&#xA;https://psoriasisclub.org/thread-8449.html</description><pubDate>27 Mar 2026 11:45 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mi226zp2ts2d</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhsijuqm722j</link><description>Adiponectin (APN) holds potential as an anti-psoriatic agent  targeting Aurora kinase A (AURKA) and Forkhead transcription factor 1 (FOXM1) for the gene-targeted therapies in psoriasis treatment.&#xA;&#xA;#Psoriasis&#xA;&#xA;https://psoriasisclub.org/thread-8448.html</description><pubDate>24 Mar 2026 11:40 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhsijuqm722j</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhl2bzfw3s23</link><description>This study analysed psoriasis-related mRNA microarray datasets, comprising 605 psoriatic plaque samples and 611 normal samples. These datasets were integrated into a cohort to systematically identify immune-related genes associated with psoriasis.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8445.html</description><pubDate>21 Mar 2026 12:37 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhl2bzfw3s23</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhkzj5vza223</link><description>This study examined the association between radiographic structural damage and physical function (PF) in psoriatic arthritis (PsA)&#xA;&#xA;#Psoriaticarthritis&#xA;&#xA;https://psoriasisclub.org/thread-8444.html</description><pubDate>21 Mar 2026 12:23 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhkzj5vza223</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhkulq347c23</link><description>This study provides valuable insights into the role of glucocorticoid receptor (GR) expression in psoriasis and its subtypes. &#xA;&#xA;#Psoriasis &#xA;#Psoriaticarthritis&#xA;&#xA;https://psoriasisclub.org/thread-8443.html</description><pubDate>21 Mar 2026 10:55 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhkulq347c23</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhg3bgeyr22y</link><description>Blood based systemic inflammatory biomarkers are an easily accessible and cost effective tool for identifying psoriasis and partially mediating the association between psoriasis and depression.&#xA;&#xA;#Psoriasis &#xA;&#xA;#Depression &#xA;&#xA; https://psoriasisclub.org/thread-8440.html</description><pubDate>19 Mar 2026 13:11 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhg3bgeyr22y</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhdm55vmyk25</link><description>Update: &#34;Johnson &amp; Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8322-post-283580.html#pid283580</description><pubDate>18 Mar 2026 13:35 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhdm55vmyk25</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhb2fe4ggk2b</link><description>This study assessed longitudinal changes in serologic and virologic hepatitis B virus  (HBV) markers and evaluated the incidence of HBV reactivation in patients with moderate-to-severe plaque psoriasis undergoing long-term biologic therapy.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8436.html</description><pubDate>17 Mar 2026 13:12 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhb2fe4ggk2b</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mhazhzazr22b</link><description>This study demonstrated that at the time of generalized pustular psoriasis (GPP) diagnosis, patients with GPP have a high burden of both psoriasis-related complications and non–psoriasis-related comorbidities.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8435.html</description><pubDate>17 Mar 2026 12:56 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mhazhzazr22b</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mh3tf7fosk27</link><description>Being independent with no advertising it&#39;s not easy to get our forum  at &#34;Psoriasis Club&#34; noticed but recently we had a new member from Bluesky, so thank you to everyone that has given us a mention or repost.&#xA;&#xA;We appreciate it. 🙏&#xA;&#xA;#Psoriasis &#xA;&#xA;psoriasisclub.org&#xA;https://psoriasisclub.org</description><pubDate>15 Mar 2026 11:23 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mh3tf7fosk27</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mgwyjuycfs2n</link><description>Bimzelx better than Skyrizi in psoriatic arthritis first head to head study.  &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8434.html</description><pubDate>13 Mar 2026 13:12 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mgwyjuycfs2n</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mgwxkxpa222n</link><description>This study provides a mechanistic foundation for luteolin-based interventions in psoriasis. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8433.html</description><pubDate>13 Mar 2026 12:55 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mgwxkxpa222n</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mgrqpzikhk2k</link><description>This study demonstrated that strenuous exercise is associated with enhanced cutaneous, systemic, and enthesis-related inflammatory changes in an imiquimod (IMQ) induced psoriasis mouse model. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8432.html</description><pubDate>11 Mar 2026 11:09 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mgrqpzikhk2k</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mghmqfvnhs2i</link><description>This study found a non-linear positive relation between body roundness index (BRI) and Psoriasis (Pso)&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8429.html</description><pubDate>07 Mar 2026 10:31 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mghmqfvnhs2i</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3mghlzgx6nk2i</link><description>Ocadusertib is a selective allosteric inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) RIPK1 inhibitors have shown potential for the treatment of psoriasis but thus far, none have been approve. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8428.html</description><pubDate>07 Mar 2026 10:18 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3mghlzgx6nk2i</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3meqjsue45k2j</link><description>Balinatunfib is being developed as a potential new treatment for patients with psoriasis that selectively inhibits TNFR1 signalling to potentially stop or slow the disease-causing processes, while preserving signals initiated through TNFR2.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8424.html</description><pubDate>13 Feb 2026 12:42 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3meqjsue45k2j</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3meqhrlnj6s2j</link><description>These results suggest that the LIGHT/TNFSF14 axis may play a key role in regulating cytokine production by autoimmune cells and related pathways in psoriasis.&#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8423.html</description><pubDate>13 Feb 2026 12:06 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3meqhrlnj6s2j</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3meqh5lhu6c2j</link><description>This study identifies a novel role for G protein-coupled receptor 108 (GPR108) as a negative regulator of TLR7 signalling in psoriasis and may yield new therapeutic principles for managing psoriatic diseases. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8422.html</description><pubDate>13 Feb 2026 11:55 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3meqh5lhu6c2j</guid></item><item><link>https://bsky.app/profile/psoriasisclub.org/post/3meiwnsxsks2m</link><description>Alterations in neural innervation within psoriatic skin &amp; delineate the functional contributions of sensory neuron-derived mediators, including ion channels, receptors, &amp; neuropeptides in modulating psoriasis-associated immune dysregulation. &#xA;&#xA;#Psoriasis &#xA;&#xA;https://psoriasisclub.org/thread-8421.html</description><pubDate>10 Feb 2026 12:11 +0000</pubDate><guid isPermaLink="false">at://did:plc:6ohdlnvgxa5yoisk6d46h442/app.bsky.feed.post/3meiwnsxsks2m</guid></item></channel></rss>